TY - DATA T1 - Additional file 2: Figure S1. of Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer PY - 2017/02/01 AU - Sara Duhachek-Muggy AU - Yue Qi AU - Randi Wise AU - Linda Alyahya AU - Hui Li AU - Jacob Hodge AU - Anna Zolkiewska UR - https://springernature.figshare.com/articles/figure/Additional_file_2_Figure_S1_of_Metalloprotease-disintegrin_ADAM12_actively_promotes_the_stem_cell-like_phenotype_in_claudin-low_breast_cancer/4672447 DO - 10.6084/m9.figshare.c.3697165_D4.v1 L4 - https://ndownloader.figshare.com/files/7625743 KW - Breast cancer KW - Cancer stem cells KW - Epidermal growth factor receptor KW - Epithelial-to-mesenchymal transition KW - ADAM metalloprotease N2 - ADAM12 mRNA is upregulated in claudin-low breast cancers. a Heatmap showing ADAM12 mRNA expression levels in 295 breast cancer patients from the Netherlands Cancer Institute (NKI) database [31]. Molecular subtypes of tumors are: B, basal; CL, claudin-low; HER2+, HER2-enriched; LumA, luminal A; LumB, luminal B; NL, normal-like. b Expression levels of ADAM12 in 508 breast cancer patients from The Cancer Genome Atlas (TCGA, Nature 2012 dataset) [33]. (TIF 4437 kb) ER -